Annual FCF
-$23.61 M
-$3.18 M-15.54%
31 December 2023
Summary:
Chemomab Therapeutics annual free cash flow is currently -$23.61 million, with the most recent change of -$3.18 million (-15.54%) on 31 December 2023. During the last 3 years, it has fallen by -$18.33 million (-347.23%). CMMB annual FCF is now -347.23% below its all-time high of -$5.28 million, reached on 31 December 2020.CMMB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
N/A
01 September 2024
Summary:
Chemomab Therapeutics quarterly free cash flow is not available.CMMB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
N/A
01 September 2024
Summary:
Chemomab Therapeutics TTM free cash flow is not available.CMMB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMMB Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.5% | - | - |
| 3 y3 years | -347.2% | - | - |
| 5 y5 years | - | - | - |
CMMB Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -347.2% | at low | ||||
| 5 y | 5 years | -347.2% | at low | ||||
| alltime | all time | -347.2% | at low |
Chemomab Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$23.61 M(+15.5%) | - | - |
| June 2023 | - | -$7.49 M(+4.2%) | -$25.68 M(+7.4%) |
| Mar 2023 | - | -$7.19 M(+26.0%) | -$23.90 M(+16.9%) |
| Dec 2022 | -$20.44 M(+62.0%) | -$5.70 M(+7.7%) | -$20.44 M(+15.1%) |
| Sept 2022 | - | -$5.30 M(-7.3%) | -$17.76 M(+18.1%) |
| June 2022 | - | -$5.71 M(+53.3%) | -$15.04 M(+0.0%) |
| Mar 2022 | - | -$3.73 M(+23.0%) | -$15.04 M(+19.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$12.61 M(+138.9%) | -$3.03 M(+17.4%) | -$12.61 M(+13.2%) |
| Sept 2021 | - | -$2.58 M(-54.8%) | -$11.14 M(+17.5%) |
| June 2021 | - | -$5.71 M(+340.5%) | -$9.48 M(+103.8%) |
| Mar 2021 | - | -$1.30 M(-16.7%) | -$4.65 M(-11.9%) |
| Dec 2020 | -$5.28 M | -$1.56 M(+68.9%) | -$5.28 M(+41.8%) |
| Sept 2020 | - | -$921.00 K(+4.7%) | -$3.72 M(+32.9%) |
| June 2020 | - | -$880.00 K(-54.2%) | -$2.80 M(+45.8%) |
| Mar 2020 | - | -$1.92 M | -$1.92 M |
FAQ
- What is Chemomab Therapeutics annual free cash flow?
- What is the all time high annual FCF for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual FCF year-on-year change?
- What is the all time high quarterly FCF for Chemomab Therapeutics?
- What is the all time high TTM FCF for Chemomab Therapeutics?
What is Chemomab Therapeutics annual free cash flow?
The current annual FCF of CMMB is -$23.61 M
What is the all time high annual FCF for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual free cash flow is -$5.28 M
What is Chemomab Therapeutics annual FCF year-on-year change?
Over the past year, CMMB annual free cash flow has changed by -$3.18 M (-15.54%)
What is the all time high quarterly FCF for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly free cash flow is -$880.00 K
What is the all time high TTM FCF for Chemomab Therapeutics?
Chemomab Therapeutics all-time high TTM free cash flow is -$1.92 M